About: Efficacy of gamma interferon and specific antibody for treatment of microsporidiosis caused by Encephalitozoon cuniculi in SCID mice     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

AttributesValues
rdf:type
Description
  • Úloha interferonu gama (IFN-γ) v léčbě mikrosporidiózy působené druhem Encephalitozoon cuniculi byla studována pomocí adoptivních přenosů imunity a aplikací IFN-γ do SCID myší. Prokázali jsme, že adoptivní transfer CD4+ T lymfocytů z imunokopentencích myší prodloužil střední dobu přežití infikovaných SCID myší, naproti tomu přenos CD4+ T lymfocytů z myší neschopných produkovat IFN-γ neměl vliv na délku přežití. Projektivní úloha IFN-γ byla následně potvrzena cytokinovou terapií. Infikované SCID myši, kterým byl podáván IFN-γ přežívaly statisticky významně déle než myši neléčené. Současné podávání specifických anti-E. cuniculi protilátek zvyšovalo pozitivní vliv na přežívání myší. Na základě uvedených výsledků navrhujeme možné použití IFN-γ jako cytokinové terapie na léčbu mikrosporidiózy, zejména v případě CD4+ deficientních pacientů. (cs)
  • The efficacy of gamma interferon (IFN-gamma) for the treatment of microsporidiosis caused by Encephalitozoon cuniculi was studied by means of adoptive transfer and IFN-gamma administration in SCID mice. While the adoptive transfer of CD4+ T cells from immunocompetent mice prolonged survival of SCID mice infected perorally with E. cuniculi, survival was not improved by adoptive transfer of CD4+ T lymphocytes from IFN-gamma-deficient mice. The protective effect of IFN-gamma was confirmed in cytokine therapy experiments in which SCID mice receiving IFN-gamma survived significantly longer than mice receiving mock injections. The administration of serum containing specific antibodies against E. cuniculi was found to prolong the survival of concurrently IFN-gamma-treated SCID mice. The data presented in this study suggest that IFN-gamma is potentially useful as a cytokine therapy for microsporidiosis, especially in CD4(+) T-cell-deficient patients.
  • The efficacy of gamma interferon (IFN-gamma) for the treatment of microsporidiosis caused by Encephalitozoon cuniculi was studied by means of adoptive transfer and IFN-gamma administration in SCID mice. While the adoptive transfer of CD4+ T cells from immunocompetent mice prolonged survival of SCID mice infected perorally with E. cuniculi, survival was not improved by adoptive transfer of CD4+ T lymphocytes from IFN-gamma-deficient mice. The protective effect of IFN-gamma was confirmed in cytokine therapy experiments in which SCID mice receiving IFN-gamma survived significantly longer than mice receiving mock injections. The administration of serum containing specific antibodies against E. cuniculi was found to prolong the survival of concurrently IFN-gamma-treated SCID mice. The data presented in this study suggest that IFN-gamma is potentially useful as a cytokine therapy for microsporidiosis, especially in CD4(+) T-cell-deficient patients. (en)
Title
  • Efficacy of gamma interferon and specific antibody for treatment of microsporidiosis caused by Encephalitozoon cuniculi in SCID mice
  • Efficacy of gamma interferon and specific antibody for treatment of microsporidiosis caused by Encephalitozoon cuniculi in SCID mice (en)
  • Účinnost interferonu gama a specifických protilátek v léčbě mikrosporidiózy způsobené druhem Encephalitozoon cuniculi na modelu SCID myší (cs)
skos:prefLabel
  • Efficacy of gamma interferon and specific antibody for treatment of microsporidiosis caused by Encephalitozoon cuniculi in SCID mice
  • Efficacy of gamma interferon and specific antibody for treatment of microsporidiosis caused by Encephalitozoon cuniculi in SCID mice (en)
  • Účinnost interferonu gama a specifických protilátek v léčbě mikrosporidiózy způsobené druhem Encephalitozoon cuniculi na modelu SCID myší (cs)
skos:notation
  • RIV/60077344:_____/08:00318363!RIV09-GA0-60077344
http://linked.open...avai/riv/aktivita
http://linked.open...avai/riv/aktivity
  • P(GP524/03/D167), P(LC06009), Z(AV0Z60220518), Z(MSM 123100003)
http://linked.open...iv/cisloPeriodika
  • 6
http://linked.open...vai/riv/dodaniDat
http://linked.open...aciTvurceVysledku
http://linked.open.../riv/druhVysledku
http://linked.open...iv/duvernostUdaju
http://linked.open...titaPredkladatele
http://linked.open...dnocenehoVysledku
  • 365462
http://linked.open...ai/riv/idVysledku
  • RIV/60077344:_____/08:00318363
http://linked.open...riv/jazykVysledku
http://linked.open.../riv/klicovaSlova
  • murine peritoneal-macrophages; IFN-gamma; immune-response; T-lymphocytes; infection; cells; therapy; AIDS; CD4+ (en)
http://linked.open.../riv/klicoveSlovo
http://linked.open...odStatuVydavatele
  • US - Spojené státy americké
http://linked.open...ontrolniKodProRIV
  • [A5190DBE3F6B]
http://linked.open...i/riv/nazevZdroje
  • Antimicrobial Agents and Chemotherapy
http://linked.open...in/vavai/riv/obor
http://linked.open...ichTvurcuVysledku
http://linked.open...cetTvurcuVysledku
http://linked.open...vavai/riv/projekt
http://linked.open...UplatneniVysledku
http://linked.open...v/svazekPeriodika
  • 52
http://linked.open...iv/tvurceVysledku
  • Chmelař, Jindřich
  • Jelínek, Jiří
  • Kopecký, Jan
  • Salát, Jiří
http://linked.open...ain/vavai/riv/wos
  • 000256272700035
http://linked.open...n/vavai/riv/zamer
issn
  • 0066-4804
number of pages
is http://linked.open...avai/riv/vysledek of
Faceted Search & Find service v1.16.118 as of Jun 21 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 75 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software